Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Polymorphism in Gag Gene Cleavage Sites of HIV-1 Non-B Subtype and Virological Outcome of a First-Line Lopinavir/Ritonavir Single Drug Regimen

  • Jade Ghosn ,

    Contributed equally to this work with: Jade Ghosn, Constance Delaugerre

    jade.ghosn@bct.aphp.fr

    Affiliations Paris Descartes University, EA 3620, Necker University Hospital, Paris, France, AP-HP, Department of Internal Medicine and Infectious Diseases, Bicetre University Hospital, Le Kremlin-Bicetre, France

  • Constance Delaugerre ,

    Contributed equally to this work with: Jade Ghosn, Constance Delaugerre

    Affiliations Paris Descartes University, EA 3620, Necker University Hospital, Paris, France, AP-HP, Virology Department, Necker University Hospital, Paris, France

  • Philippe Flandre,

    Affiliation Inserm UMR-S 943, Virology Department, Pitié-Salpêtrière Hospital and Pierre et Marie Curie University Paris 6, Paris, France

  • Julie Galimand,

    Affiliation Paris Descartes University, EA 3620, Necker University Hospital, Paris, France

  • Isabelle Cohen-Codar,

    Affiliation Abbott France, Rungis, France

  • François Raffi,

    Affiliation Department of Infectious Diseases, Hotel-Dieu Hospital, Nantes, France

  • Jean-François Delfraissy,

    Affiliation AP-HP, Department of Internal Medicine and Infectious Diseases, Bicetre University Hospital, Le Kremlin-Bicetre, France

  • Christine Rouzioux,

    Affiliations Paris Descartes University, EA 3620, Necker University Hospital, Paris, France, AP-HP, Virology Department, Necker University Hospital, Paris, France

  • Marie-Laure Chaix

    Affiliations Paris Descartes University, EA 3620, Necker University Hospital, Paris, France, AP-HP, Virology Department, Necker University Hospital, Paris, France

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.